Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules. Department of Urogynaecology, King's College Hospital, London

Autor:	J C, Stevenson, U, Gaspard, B, Avouac, C, Bricaire, L, Cardozo, P, Collins, J P, Devogelaer, M, Dören, C, Gennari, J M, Kaufman, F, Kuttenn, J D, Ringe, C, Scarafiotti, L, Vanhaelst, L, Zichella, R, Ziegler, J Y, Reginster
Rok vydání:	2002
Předmět:	Selective Estrogen Receptor Modulators Urologic Diseases Estrogen Replacement Therapy Quality of Life Humans Coronary Disease Estrogens Female Genital Diseases Female
Zdroj:	Climacteric : the journal of the International Menopause Society. 1(1)
ISSN:	1369-7137
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::a667e07f626b51989b59b923b7a144b0 https://pubmed.ncbi.nlm.nih.gov/11913406 Zobrazit plný text záznamu